Treatment of Aggressive T Cell Lymphoblastic Lymphoma/leukemia Using Anti-CD5 CAR T Cells
2021 · Stem Cell Reviews and Reports · 75 citations
https://doi.org/10.1007/s12015-020-10092-9
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
18
Papers
171
Citations
3
h-index
3
i10-index
Hai-chan Xu is an academic researcher from Peking University Shenzhen Hospital. The author has contributed to research in topics: CAR-T cell therapy research & Immune Cell Function and Interaction & Virus-based gene therapy research. The author has an h-index of 3, co-authored 16 publications.
ORCID: 0000-0002-9202-0310https://doi.org/10.1007/s12015-020-10092-9
https://doi.org/10.3389/fimmu.2025.1604490
Click to start Chat